{"nct_id":"NCT03934372","title":"Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2020-01-29","start_date_type":"ACTUAL","primary_completion_date":"2026-01-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-01-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}